Filter posts

The Burrill Report Interview with Jim Greenwood

The Burrill Report’s Daniel Levine spoke with Jim Greenwood, president and CEO of BIO, about …

Development continues for osteoporosis drug

Osteologix, Inc. (OLGX.OB) will continue the clinical development for its osteoporosis drug, NB S101 (strontium …

Oncolytics invests in private biotech company

Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) invested in British Canadian Biosciences Corp., a privately …

Podcast with Fast Forward's Tim Coetzee

Biotech Now’s Tracy Krughoff spoke with Dr. Tim Coetzee, president of Fast Forward, a subsidiary …

Q&A with Complete Genomics' Dr. Clifford Reid

Read a recent interview with Complete Genomics Chairman, President, and CEO Clifford Reid about his …

A BIO Investor Forum Success Story

A year ago, CombinatoRx probably wouldn’t have guessed a multi-million dollar merger was on the …

Podcast with Debra Miller, Cure Duchenne

Biotech-Now’s Tracy Krughoff spoke with Cure Duchenne’s President, Debra Miller. Cure Duchenne will be one …

Novavax launches study of novel H1N1 vaccine in Mexico

Novavax, Inc. (Nasdaq: NVAX) initiated a two-stage clinical study of its virus-like-particle (VLP) H1N1 influenza …

Clinical trial results for Calistoga Pharmaceuticals’ CAL-101

Calistoga Pharmaceuticals, Inc., announced interim results from the ongoing Phase 1 trial evaluating CAL-101, a …

Trubion reports positive data from Phase 2B TRU-015 study

Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) announced favorable safety and efficacy data following administration of a …